Sundeep Dugar - Concepedia

Author

Sundeep Dugar

University of California San Diego ORCID

Also Known As

S Dugar, S. DUGAR, S. Dugar, Sundeep Dugar

105

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

University of California San Diego Sphaera Pharma (India)Instituto Politécnico Nacional University of California System Sphaera Pharma (Singapore)

About

Sundeep Dugar is an author at University of California San Diego specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	24	1.1K
2	Natural Sciences	12	13	487
3	Engineering	4	4	178
4	Health Sciences	3	3	130
5	Public Health	2	2	70

Sundeep Dugar

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Progressive Transforming Growth Factor β1–induced Lung Fibrosis Is Blocked by an Orally Active ALK5 Kinase Inhibitor Philippe Bonniaud, Peter J. Margetts, Martin Kolb, American Journal of Respiratory and Critical Care Medicine FibrosisInflammatory Lung DiseaseLung InflammationLung Fibrosis IsImmunology	2004	252
Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase <i>In vivo</i> Rongrong Ge, Vaishali Rajeev, Partha Ray, Clinical Cancer Research	2006	152
Targeting Endogenous Transforming Growth Factor β Receptor Signaling in SMAD4-Deficient Human Pancreatic Carcinoma Cells Inhibits Their Invasive Phenotype Gayathri Subramanian, Roderich E. Schwarz, Linda S. Higgins, Cancer Research	2004	134
2-Azetidinone Cholesterol Absorption Inhibitors: Structure−Activity Relationships on the Heterocyclic Nucleus John W. Clader, Duane A. Burnett, Mary Ann Caplen, Journal of Medicinal Chemistry Medicinal ChemistryHeterocyclicPharmacological StudyBiochemistryOxysterol	1996	133
p38α-Selective Mitogen-Activated Protein Kinase Inhibitor SD-282 Reduces Inflammation in a Subchronic Model of Tobacco Smoke-Induced Airway Inflammation Satyanarayana Medicherla, Mary F. Fitzgerald, Dianne Spicer, Journal of Pharmacology and Experimental Therapeutics	2007	94
Inhibiting TGF-β signaling restores immune surveillance in the SMA-560 glioma model Thomas-Toan Tran, Martin Uhl, Ying Jing, Neuro-Oncology Restores Immune SurveillanceImmune RegulationImmunologyImmunoeditingHigh-grade Gliomas	2007	94
Stoichiometric synthesis of unsymmetrical mononitrobiphenyls via the palladium-catalyzed cross-coupling of arylboronic acids with aryl bromides Rebecca Miller, Sundeep Dugar Organometallics EngineeringAltmetric Attention ScoreOrganic ChemistryChemistryPalladium-catalyzed Cross-coupling	1984	82
Inhibition of p38α MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-XL, Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo Tony Navas, Anthony Nguyen, Teru Hideshima, Leukemia Tumor BiologyP53 LevelsMedicineApoptosisMyeloma Cells	2006	80
A Selective p38α Mitogen-Activated Protein Kinase Inhibitor Reverses Cartilage and Bone Destruction in Mice with Collagen-Induced Arthritis Satyanarayana Medicherla, Ying Jing, Ruban Mangadu, Journal of Pharmacology and Experimental Therapeutics	2006	77
Transforming Growth Factor-β Receptor Type 1 (TGFβRI) Kinase Activity but Not p38 Activation Is Required for TGFβRI-Induced Myofibroblast Differentiation and Profibrotic Gene Expression Ann M. Kapoun, N. J. Gaspar, Ying Wang, Molecular Pharmacology	2006	75

Page 1